Standout Papers

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria 2006 2026 2012 2019 845
  1. The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (2006)
    Peter Hillmen, Neal S. Young et al. New England Journal of Medicine
  2. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease (2016)
    Kenneth I. Ataga, Abdullah Kutlar et al. New England Journal of Medicine
  3. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (2007)
    Russell P. Rother, Scott A. Rollins et al. Nature Biotechnology

Immediate Impact

6 by Nobel laureates 15 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Complement in breast milk modifies offspring gut microbiota to promote infant health
2024 Standout
The role of platelets in immune-mediated inflammatory diseases
2023 Standout
4 intermediate papers

Works of Scott A. Rollins being referenced

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
2016 Standout
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
Scott A. Rollins 4009 1498 1853 63 7.1k
Russell P. Rother 4508 712 2271 71 7.7k
H. Terence Cook 6377 566 1266 122 9.5k
Laure‐Hélène Noël 2236 954 1080 178 7.9k
D. Robert Sutherland 2227 603 3068 97 7.2k
Timothy H.J. Goodship 5838 465 2542 137 8.4k
Lubka T. Roumenina 5417 283 1951 134 7.8k
David Kavanagh 5619 221 2256 137 7.7k
X. Long Zheng 3690 368 3092 178 5.7k
Denisa D. Wagner 2229 1067 5524 80 9.3k
Élie Haddad 3127 462 1846 174 6.7k

All Works

Loading papers...

Rankless by CCL
2026